Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading
Sissel Hauge et al.
ONCOTARGET (2017)
A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis
Yasuyoshi Miyata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1
Pei Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types
Joanna Kruk et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
G. Chen et al.
ONCOGENE (2017)
The Roles of ROS in Cancer Heterogeneity and Therapy
Paulo Luiz de Sa Junior et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Upregulation of WEE1 is a potential prognostic biomarker for patients with colorectal cancer
Xiao-Chuan Ge et al.
ONCOLOGY LETTERS (2017)
The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer
Chiyao Hsueh et al.
ONCOTARGET (2017)
Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer
Jill J. J. Geenen et al.
CLINICAL CANCER RESEARCH (2017)
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer
Amanda L. Richer et al.
CANCER RESEARCH (2017)
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Sandeo Prasad et al.
CANCER LETTERS (2017)
Mechanisms of a novel anticancer therapeutic strategy involving atmospheric pressure plasma-mediated apoptosis and DNA strand break formation
Woo-Hyun Chung
ARCHIVES OF PHARMACAL RESEARCH (2016)
A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells (vol 11, pg 921, 2016)
Christopher J. Matheson et al.
ACS CHEMICAL BIOLOGY (2016)
Expression and prognostic value of the WEE1 kinase in gliomas
Darija Music et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Targeting WEE1 Kinase in Cancer
Christopher J. Matheson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Expression and clinical significance of Wee1 in colorectal cancer
Eivind Valen Egeland et al.
TUMOR BIOLOGY (2016)
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair
Tasneem Kausar et al.
NEOPLASIA (2015)
Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence
Abdullah A. Osman et al.
MOLECULAR CANCER THERAPEUTICS (2015)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
Ana Slipicevic et al.
GYNECOLOGIC ONCOLOGY (2014)
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
Gry Irene Magnussen et al.
BMC CANCER (2013)
The antioxidant paradox: less paradoxical now?
Barry Halliwell
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
Amy D. Guertin et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
Jenny M. Kreahling et al.
PLOS ONE (2013)
High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
Gry Irene Magnussen et al.
PLOS ONE (2012)
MK-1775, a small molecule Wee1 inhibitor, enhances antitumor efficacy of various DNA-damaging agents, including 5-fluorouracil
Hiroshi Hirai et al.
CANCER BIOLOGY & THERAPY (2010)
Improvement of Multivariate Image Analysis Applied to Quantitative Structure-Activity Relationship (QSAR) Analysis by Using Wavelet-Principal Component Analysis Ranking Variable Selection and Least-Squares Support Vector Machine Regression: QSAR Study of Checkpoint Kinase WEE1 Inhibitors
Rodrigo A. Cormanich et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Production of reactive oxygen species in response to replication stress and inappropriate mitosis in fission yeast
MA Marchetti et al.
JOURNAL OF CELL SCIENCE (2006)
The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer
T Yoshida et al.
ANNALS OF ONCOLOGY (2004)
Share Paper
